New Alzheimer Drugs on the Horizon!
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
EYES ON<br />
THE<br />
PRIZE<br />
Aducanumab is <strong>the</strong> first drug to exhibit a dual effect <strong>on</strong> both plaque<br />
destructi<strong>on</strong> and cognitive decline. C<strong>on</strong>clusive data is three years away. The<br />
outcome of solanezumab will be evident <strong>on</strong>e year from now. Results of<br />
gantenerumab and crenezumab will follow.<br />
As research efforts get closer to a cure for AD, we can be grateful for <strong>the</strong><br />
diligence of scientists. With <strong>the</strong>ir c<strong>on</strong>tinued perseverance, we can look<br />
forward to <strong>the</strong> day when AD is a faded memory.
![Projected Senior Populations in the State of Ohio [Infographic]](https://img.yumpu.com/54840652/1/190x107/projected-senior-populations-in-the-state-of-ohio-infographic.jpg?quality=85)
Change language